Policymakers & International health organisations

The LOS provides policymakers and international health organisations with an invaluable resource for informed decision-making. By offering comprehensive, long-term data on the effects of blood transfusions and donations, LOS enables the development of evidence-based policies and guidelines. This wealth of information allows for a more nuanced understanding of the long-term implications of transfusion practices, helping to shape national blood strategies and international health policies. Policymakers can use this data to allocate resources more effectively, prioritize research areas, and implement regulations that enhance patient safety and improve overall public health outcomes in the field of transfusion medicine.

Rapid response to global health threats

The LOS Registry has the potential to facilitate rapid responses to global health threats. The centralised, digital nature of the registry enables the monitoring of transfusion-related trends and outcomes in different populations. In the event of a pandemic or other health crisis that impacts blood supply or transfusion practices, policy makers can make data-driven decisions. This data analysis can be critical to developing timely and effective strategies for managing blood resources and maintaining public health during emergencies.

Standardisation and international cooperation

LOS promotes the standardisation of data collection and reporting across countries and health systems. This standardisation is particularly valuable for international healthcare organisations as it enables more accurate comparisons of transfusion practices and outcomes across borders. Compliance with EU haemovigilance and GDPR standards enabled the highest data quality and effective data protection. In addition, the collaborative nature of LOS promotes international cooperation in transfusion medicine research and practice and fosters a global community of experts working towards common goals in patient safety and quality of care.

Long-term planning and optimisation of healthcare systems

The 30-year longitudinal data provided by LOS offers policy makers and healthcare organisations an unprecedented opportunity for long-term healthcare planning. By understanding the long-term impact of transfusion practices, policymakers can anticipate future health needs and challenges related to blood transfusion and donation. This foresight enables more effective resource allocation, workforce planning and optimisation of the healthcare system. In addition, the knowledge gained from LOS can inform the development of prevention strategies and measures, which could reduce the long-term burden of transfusion-related complications on healthcare systems.R